Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Serina Therapeutics (SER) has shared an announcement.
Serina Therapeutics, Inc. has bolstered its executive team by appointing Dr. Srini Tenjarla as the new Senior Vice President of CMC & Formulation. With a rich background from Takeda Pharmaceuticals and prior experience at Shire Pharmaceuticals, Dr. Tenjarla brings a wealth of expertise in drug product development to oversee Serina’s expanding pipeline. His academic credentials include a Ph.D. in Pharmaceutical Sciences and a B.Sc. in Pharmacy, promising to enhance the company’s capacity in bringing new therapies to market.
Learn more about SER stock on TipRanks’ Stock Analysis page.
